Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Current assets:
Cash and cash equivalents	$ 121,540	$ 92,154
Accounts receivable, net	72,015	129,122
Prepaid expenses and other current assets	14,619	12,012
Total current assets	208,174	233,288
Property and equipment, net	5,288	5,585
Operating lease right-of-use assets	12,208	12,586
Intangible assets, net	3,478	3,682
Deferred tax assets	206,273	212,324
Other assets	3,398	3,608
Total assets	438,819	471,073
Current liabilities:
Accounts payable	6,222	7,830
Accrued research and development costs	11,880	21,331
Accrued expenses and other current liabilities	31,398	44,254
Current portion of operating lease liabilities	3,142	3,126
Current portion of convertible senior notes	199,800	199,560
Total current liabilities	252,442	276,101
Convertible senior notes, net of current portion	198,477	198,309
Operating lease obligations, net of current portion	14,004	14,543
Revolving credit facility	275,000	300,000
Other liabilities	29,414	28,415
Commitments and contingencies
Stockholders' equity (deficit):
Class A Common Stock, $0.001 par value, 500,000,000 shares authorized and 158,957,123 shares issued and outstanding at March 31, 2024 and 500,000,000 shares authorized and 156,354,238 shares issued and outstanding at December 31, 2023	159	156
Additional paid-in capital	1,373,022	1,355,195
Accumulated deficit	(1,702,777)	(1,698,615)
Accumulated other comprehensive loss	(922)	(3,031)
Total stockholders' deficit	(330,518)	(346,295)
Total liabilities and stockholders' deficit	$ 438,819	$ 471,073